glp 1 agonist indications GLP-1 Receptor Agonists TrimRX | GLP-1 vs GIP:
Description
Ozempic is approved for type 2 diabetes (0.25 mg to 2 mg), while Wegovy is approved for chronic weight management (up to 2.4 mg) and to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity Exenatide extended-release (Bydureon BCise) : Once-weekly injection using microsphere technology Liraglutide (Victoza, Saxenda) : Once-daily injection
The company has continued to use this language, including for its new oral product
The science, as its described, is transdermal delivery
The baseline characteristics of the five groups are listed in Supplementary Table S1
